Press Releases
Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the treatment of non-hospitalized adult and adolescent patients who are at high risk of progression to...
Packaging & Labelling
Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility
Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.
The investment at...
Drug Research
TrakCel and Korber partner to provide orchestration within manufacturing of cell and gene therapies
TrakCel, a leading supplier of cellular orchestration solutions for the cell and gene therapy industry, announces it is launching a software integration resulting from a collaborative, non-exclusive partnership with Körber, the specialists for complete handling systems for pharmaceutical and...
Press Releases
Sterling Pharma Solutions Expands Early Phase Development Capabilities at Cary
Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced that it has commenced a $2.1 million expansion project to increase chemical and analytical capabilities at its facility in Cary, North Carolina.
The project will include the construction of...
Drug Research
West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced an exclusive supply and technology agreement with Corning Incorporated. The new collaboration includes a multimillion-dollar investment to expand Corning's Valor® Glass technology to enable...
Drug Research
Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell -based disease modelling for ophthalmologic disorders. Millions of people are affected by vision-related diseases worldwide, and there...
Packaging & Labelling
Vetter’s new clinical manufacturing site now officially authorized
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.